Severe interstitial injury was present in six patients, five of whom were receiving a CNI-based immunosuppression protocol, while the other one was receiving mTOR inhibitor only (CNI treatment had been discontinued six months before renal biopsy due to hepatocellular carcinoma relapse). Here, MTOR is linked to hepatocellular carcinoma.